...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Australian and New Zealand journal of psychiatry >A Dutch guideline for the use of clozapine.
【24h】

A Dutch guideline for the use of clozapine.

机译：荷兰使用氯氮平的指南。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

In this journal Les R.H. Drew recently wrote that an urgent review was needed of the strict controls on clozap-ine, which are mainly directed at preventing agranulocy-tosis. He also referred to the extensive international literature on monitoring systems for clozapine treatment and suggested that new requirements might be appropriate with respect to other disabling and potentially fatal complications associated with clozapine [1]. It may be of interest to readers of this journal that in the European Union the use of clozapine is not restricted to hospitals. White blood cell counts (WBC) are mandatory weekly during the first 18 weeks and every four weeks thereafter. The results have to be reviewed by the prescribing doctor, but the patient does not have to see the doctor every time.
机译：Les R.H. Drew最近在该期刊中写道，需要对氯氮平的严格控制进行紧急审查，氯氮平的严格控制主要是为了预防粒状肌病。他还参考了有关氯氮平治疗监测系统的大量国际文献，并建议对于氯氮平相关的其他致残和潜在致命并发症，新的要求可能是合适的[1]。该杂志的读者可能会感兴趣，在欧盟，氯氮平的使用不仅限于医院。在头18周内必须每周进行白细胞计数（WBC），此后每4周进行一次。结果必须由开处方的医生检查，但患者不必每次都去看医生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号